Announcements Trials
Browse Landscape

Status

Completed 11Unknown 4Recruiting 4Withdrawn 3Active not recruiting 3Enrolling by invitation 2Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 3NIH 2OTHER_GOV 1

Study Type

Observational 3

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2Cardiotoxicity 2Cardiovascular Diseases 1Breast Neoplasms 1Atherosclerosis 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Echocardiography × Clear all
NCT05036252 2025-09-30

Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity

Memorial Sloan Kettering Cancer Center

Active not recruiting
23 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT05201014 2025-09-05

CASCADE

Mayo Clinic

Active not recruiting
112 enrolled

Cardiovascular Diseases, Neoplasms

NCT06597045 2024-09-19

BIOCAPRI

NHS Greater Glasgow and Clyde

Active not recruiting
60 enrolled

Neoplasms, Atherosclerosis, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡